A number of research firms have changed their ratings and price targets for Aveanna Healthcare (NASDAQ: AVAH):
- 11/14/2026 – Aveanna Healthcare was upgraded by Wall Street Zen from “buy” to “strong-buy”.
- 11/13/2026 – Aveanna Healthcare was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
- 11/13/2026 – Aveanna Healthcare had its “outperform” rating reaffirmed by Royal Bank Of Canada.
- 11/12/2026 – Aveanna Healthcare had its “strong-buy” rating reaffirmed by Raymond James Financial.
- 10/14/2026 – Aveanna Healthcare was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
- 9/29/2026 – Aveanna Healthcare had its “hold (c+)” rating reaffirmed by Weiss Ratings.
Aveanna Healthcare Stock Performance
NASDAQ:AVAH opened at $11.63 on Tuesday. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $14.71. The company has a 50 day simple moving average of $12.98 and a two-hundred day simple moving average of $9.47. The company has a market capitalization of $2.54 billion, a PE ratio of 8.49, a P/E/G ratio of 0.75 and a beta of 2.03.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.02. Aveanna Healthcare had a net margin of 11.44% and a return on equity of 70.01%. The firm had revenue of $695.54 million for the quarter, compared to the consensus estimate of $679.48 million. Research analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.77 earnings per share for the current year.
Insider Activity
In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 2,250,000 shares of Aveanna Healthcare stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the sale, the insider directly owned 12,315,892 shares in the company, valued at approximately $141,632,758. The trade was a 15.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 2,250,000 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the transaction, the insider directly owned 12,315,892 shares in the company, valued at approximately $141,632,758. This trade represents a 15.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 48,566,081 shares of company stock worth $558,509,932. 5.30% of the stock is owned by insiders.
Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities. The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.
Read More
- Five stocks we like better than Aveanna Healthcare
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake
- Tyson Foods’ 10% Surge Puts a Breakout in Sight, But Wall Street Remains Cautious
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
Receive News & Ratings for Aveanna Healthcare Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
